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Abstract
Introduction: Ex vivo expansion of umbilical cord blood (UCB) is attempted to increase cell numbers to overcome
the limitation of cell dose. Presently, suspension cultures or feeder mediated co-cultures are performed for
expansion of hematopoietic stem cells (HSCs). Mesenchymal stem cells (MSCs) have proved to be efficient feeders
for the maintenance of HSCs. Here, we have established MSCs-HSCs co-culture system with MSCs isolated from less
invasive and ethically acceptable sources like umbilical cord tissue (C-MSCs) and placenta (P-MSCs). MSCs derived
from these tissues are often compared with bone marrow derived MSCs (BM-MSCs) which are considered as a gold
standard. However, so far none of the studies have directly compared C-MSCs with P-MSCs as feeders for ex vivo
expansion of HSCs. Thus, we for the first time performed a systematic comparison of hematopoietic supportive
capability of C and P-MSCs using paired samples.
Methods: UCB-derived CD34+ cells were isolated and co-cultured on irradiated C and P-MSCs for 10 days. C-MSCs
and P-MSCs were isolated from the same donor. The cultures comprised of serum-free medium supplemented with
25 ng/ml each of SCF, TPO, Flt-3 L and IL-6. After 10 days cells were collected and analyzed for phenotype and
functionality.
Results: C-MSCs and P-MSCs were found to be morphologically and phenotypically similar but exhibited
differential ability to support ex vivo hematopoiesis. Cells expanded on P-MSCs showed higher percentage of
primitive cells (CD34+CD38−), CFU (Colony forming unit) content and LTC-IC (Long term culture initiating cells)
ability. CD34+ cells expanded on P-MSCs also exhibited better in vitro adhesion to fibronectin and migration
towards SDF-1α and enhanced NOD/SCID repopulation ability, as compared to those grown on C-MSCs. P-MSCs
were found to be closer to BM-MSCs in their ability to expand HSCs. P-MSCs supported expansion of functionally
superior HSCs by virtue of reduction in apoptosis of primitive HSCs, higher Wnt and Notch activity, HGF secretion
and cell-cell contact. On the other hand, C-MSCs facilitated expansion of progenitors (CD34+CD38+) and
differentiated (CD34−CD38+) cells by secretion of IL1-α, β, MCP-2, 3 and MIP-3α.
Conclusions: P-MSCs were found to be better feeders for ex vivo maintenance of primitive HSCs with higher
engraftment potential than the cells expanded with C-MSCs as feeders.
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Introduction
Over the past two decades, umbilical cord blood (UCB)
has developed into an attractive and alternative source
of hematopoietic stem cells (HSCs) both in clinics and
in research. However, insufficient numbers of HSCs in
the UCB limits its application in adults as an allogeneic
source of HSCs for the transplantation [1]. The limited
cell dose can be enhanced either by performing double
CB transplantation (DCBT) or by ex vivo expansion of
UCB. Ex vivo expansion stands out to be the most con-
venient option over the DCBT since, in the latter, there
is successful engraftment of only a single CB unit with
an elevated risk of graft versus host disease [1–4].
Currently, HSCs are expanded in the presence of a
combination of cytokines [4–6]. However, under in vivo
conditions, HSCs are reliant upon the cytokines and also
on the varied components from their niche, such as
mesenchymal stem cells (MSCs), endothelial cells, osteo-
blasts, etc., and extra cellular matrix for their mainten-
ance and differentiation [7]. This emphasizes the need
for an optimized culture system which closely resembles
the in vivo niche and supports the growth of HSCs in
vitro. Various cell types from the niche are used for the
expansion of HSCs, but MSCs in particular are found to
be efficient in sustaining the ex vivo expansion of HSCs
[8–11].
Although BM remains the main source of MSCs, here
we have established MSCs-HSCs co-cultures with MSCs
isolated from non-invasive sources, such as umbilical
cord and placenta [12]. It is reported that MSCs ob-
tained from these sources are morphologically and
phenotypically comparable with BM-MSCs [13, 14]. C-
MSCs may be situated as an alternative to BM-MSCs in
the field of HSCs transplantation as opposed to P-MSCs
which are primarily explored as a valuable source for cell
replacement therapies. Despite intensive investigation, to
the best of our knowledge no report has directly com-
pared the HSCs supportive function of these two stromal
populations. We report here a unique observation that
C-MSCs and P-MSCs have differential propensities for
the maintenance of HSCs. To decipher the basis of the
differential ability of these feeders to support the ex vivo
maintenance and propagation of HSCs we isolated C-
MSCs and P-MSCs from the same donor.
We demonstrate here that P-MSCs make better feeders
than C-MSCs, and were found to possess similar potential
as BM-MSCs for expansion of primitive UCB HSCs. Con-
versely, expansion mediated by C-MSCs was primarily
dependent on the pro-inflammatory cytokines secreted by
them yielding differentiated cells. We also report that the
differences observed are a reflection of not only the prom-
inent activation of Wnt and Notch signals but also of
improved survival signals from P-MSCs as opposed to
C-MSCs. Based on all the findings, we conclude that
P-MSCs are the most suitable feeders for the ex vivo
maintenance of functional HSCs.
Methods
Ethical approvals for human samples and animal
experiments
UCB samples, placenta, and cord were collected from local
hospitals after obtaining informed consent with the com-
pliance of the institutional review board (IEC-Institutional
ethical committee –NCCS and IC-SCR –Institutional
Committee for Stem Cell Research, NCCS) according to
the Declaration of Helsinki. Consenting procedures were
also approved by the NCCS-IC-SCR- Institutional Com-
mittee for Stem Cell Research, NCCS.
Protocols for animal experiments were approved and in
accordance with the IAEC-NCCS Institutional Animal
Ethical Committee-NCCS/CPCSEA- Committee for the
Purpose of Control and Supervision of Experiments on
Animals. (Approval number: IACUC-Institutional Animal
Care and Use Committee, EAF-Experimental Animal
Facility/2004/B-71(III)). Throughout the experiments ani-
mals were under the supervision of trained personnel.
Collection of umbilical cord blood and isolation of CD34+
cells
Cord blood samples were collected from local hospitals
after obtaining informed consent with the compliance of
the institutional review board (IEC-Institutional ethical
committee and IC-SCRT –Institutional Committee for
Stem Cell Research, NCCS) according to the Declaration
of Helsinki. Consenting procedures were also approved
by the IC-SCR- Institutional Committee for Stem Cell Re-
search, NCCS. Mononuclear cells were isolated by the ficoll
hypaque density gradient method (density 1.077 g/ml,
Sigma Aldrich, St. Louis MO, USA). CD34+ cells were iso-
lated by the positive selection method using Dynal beads
according to the manufacturer’s instructions (Dynabeads
M-450 CD34; Dynal, ASA, Oslo, Norway).
Isolation of mesenchymal stem cells from cord tissue and
placenta
Umbilical cord and placenta were collected from full term
deliveries after obtaining informed consent in accordance
with the IEC-Institutional ethical committee and IC-
SCRT- Institutional Committee for Stem Cell Research,
NCCS. The umbilical cord and a central piece from the
placenta were used to isolate the mesenchymal stem cells.
The detailed procedure is explained in Ref [15]. Cells be-
tween passages three to six were used for the experiments
after carrying out the phenotypic characterization of the
MSCs. Phenotypic characterization and differentiation to
osteoblasts and adipocytes and chondrocytes was carried
out as explained in [15].
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Isolation of mesenchymal stem cells from bone marrow
BM-MSCs were a kind gift from Dr.Mohan Wani, NCCS
(Pune). BM-MSCs were cultured in RPMI + 20 % Mesen
FBS (GIBCO, Grand Island, NY, USA). Phenotypic
characterization and differentiation to osteoblasts and
adipocytes was carried out as explained earlier [15].
Chondrogenic differentiation was carried out using a
StemPro Chondrogenesis kit (Invitrogen, Grand Island,
NY, USA) according to the manufacturer’s instructions.
Establishment of co-cultures of MSCs and HSCs in
serum-free medium
MSCs were seeded in 24-well plates (BD Falcon, San Jose,
CA, USA) at a cell density of 104 cells/well and were
grown until confluence. The monolayers were then irradi-
ated at 8,000 rads and 5 × 104-1 × 105 UCB CD 34+ cells
in Stem Pro Serum Free medium (GIBCO) were seeded
onto the monolayers for contact cultures. For non-contact
cultures, 104 cells were seeded on 3 μm cell culture in-
serts (Millicell, Millipore, San Diego, USA). The co-
cultures were incubated for ten days in the presence of
a growth factor cocktail containing IL-6, SCF, TPO, and
Flt-3-L. All growth factors (Peprotech Inc., Rocky Hill,
NJ, USA) were used at a final concentration of 25 ng/
ml. After ten days both the non-adherent and adherent
fractions were collected and studied for various param-
eters such as phenotypic characterization, in vitro func-
tionality assessment, and in vivo engraftment studies in
NOD/SCID mice. Assessment of these parameters was
carried out using independent cord blood samples.
Flow cytometry analysis
The expanded cells were subjected to phenotypic
characterization using a panel of anti-bodies. For the
detection of intracellular proteins the cells were perme-
abilized using a BD fixperm kit (BD Pharmingen, San
Jose, CA, USA) and the staining was done according to
the manufacturer’s instructions. Isotype matched anti-
bodies were used as controls. The fluorescently labeled
cells were acquired on FACS Canto II and Aria (BD,
San Jose, CA, USA) and data were analyzed by FACS
DIVA - version 5.0 The details of the antibodies used
are as follows: annexin V FITC, CD34 APC/PE, CD38
FITC, Bcl-2 PE, Bax FITC, CD33 FITC/PE, CD19 APC
CD3 FITC, CD61 APC, CD45 PE/PE-CY-7 murine
CD45.1 Pacific blue (BD Pharmingen) and CD133 PE
(Milteny Biotech, Colonge, Germany).
Colony-forming unit (CFU) assay
Expanded cells (2 × 104) were cultured in 1 % methyl-
cellulose (Sigma Aldrich) with a combination of the
growth factors: SCF 20 ng/mL, GM-CSF 2 ng/mL, IL-3
4 ng/mL, and Epo 2 U/mL. The plates were incubated
under humidified conditions at 37 °C, in 5 % CO2 for
14 days. Based on the differential morphology of the
colonies they were scored as blast-forming unit erythroid
(BFU-E), granulocyte-monocyte (GM), granulocyte-
erythroid-monocyte-megakaryocyte (GEMM), and mega-
karyocytes (MK).
Long-term culture initiating cell (LTC-IC) assay
M210B4 (murine stromal cell line, ATCC) cells was
grown on collagen-coated wells of 24-well plates to con-
fluency. The plates were gamma-irradiated (8,000 rads)
and 1 × 105 expanded cells were seeded on feeder layers
in human myelocult medium (Stem Cell Technology,
Vancouver, Canada) supplemented with hydrocortisone
(10−6 M). The cultures were maintained for four to eight
weeks with weekly demi-defoliation. LTC-IC activity was
assessed by the CFU assay.
In vitro migration towards SDF1α
Expanded cells (1 × 105) were seeded in the upper cham-
ber of a transwell migration set up (8 μ BD Falcon). A
total of 100 ng of SDF 1α was added to the lower wells
containing 600 ml of medium (IMDM+ 2 % FCS). One
set was run without the addition of SDF1α as a control
to assess spontaneous migration. The cells were allowed
to migrate for five h at 37 °C. The migrated cells were
collected, manually counted and a graph of total mi-
grated cells in both sets was plotted after subtracting the
number of spontaneously migrated cells from the total
number of migrated cells. Further, the migrated fraction
was analyzed to check the CD34+CD38− content.
Cell – matrix adhesion assay
Adhesive capacities of the expanded cells were evaluated
by determining their adhesion to fibronectin. The CD34+
cells were sort purified from the expanded cells and 105
cells were seeded on fibronectin-coated 96-well plates.
The plates were incubated for 35 min (37 °C, 5 % CO2).
Unbound cells were gently washed off and the adhered
cells were fixed using 4 % paraformaldehyde (ten min, am-
bient temperature) and stained using crystal violet (0.1 %
in 70 % methanol). The plates were washed three times
using sterile distilled water to remove the excess stain and
the cells were then lysed with Triton X 100 (30 min, ambi-
ent temperature) to release the crystal violet dye. The
absorbance was measured at 550 nm. A higher absorbance
corresponded with more adhesion.
NOD/SCID repopulation assay
The NOD/LtSZ-scid/scid mice (Jackson Laboratory, Bar
Harbor, ME, USA) were bred in the animal facility of
NCCS. All the protocols were approved and in accordance
with IAEC-NCCS Institutional animal ethical committee
-NCCS/CPCSEA- Committee for the Purpose of Control
and Supervision of Experiments on Animals.(Approval
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number: IACUC-Institutional Animal Care and Use Com-
mittee, EAF-Experimental Animal Facility/2004/B-71(III)).
Throughout the experiments animals were under the
supervision of trained personnel. Mice at four to six weeks
of age were exposed to a sub-lethal dose of 300 rads
total body irradiation from a 60Co source (Gammacham-
ber5000, BRIT, Navi Mumbai, India). Expanded cells (106)
from C- and P-MSCs sets were then infused through the
tail vein into the sub-lethally irradiated mice (n = 5 – 10).
Short-term and long-term engraftment was assessed in
bone marrow and spleen at the 4th and 12th weeks after
infusion by probing human CD45+ cells against the host
murine CD45 background. The presence of greater than
0.1 % in the total nucleated cells of the recipient was con-
sidered as a successful engraftment. The multi-lineage en-
graftment from the donor was determined using a panel
of antibodies against the following markers: CD34+ (stem
cell marker), CD33 (myeloid cells), CD3, CD19, and CD56
(lymphoid cells). The antibodies were purchased from BD
Pharmingen. The respective isotype antibodies (Beckton
Dickinson, San Jose, CA, USA) were included as control.
For staining of peripheral blood, 100 μl of blood was incu-
bated with the antibodies, further RBCs were lysed with
lysis buffer (BD) and washed twice with PBS containing
0.1 % BSA. A minimum of 1,00,000 events were acquired
on FACS Canto II (BD).
Apoptosis detection by annexin V/PI assay
After ten days of expansion, cells were harvested and
105 cells were taken for annexinV/PI staining. Briefly,
the cells were first washed with PBS and re-suspended
in 1 × binding buffer. A total of 5 μL of annexin V FITC
(BD Biosciences) was added and incubated at room
temperature for 20 min. Cells were again washed with 1
× binding buffer to remove the excess of antibody. Prior
to acquisition on flow cytometer, 0.5 μg of propidium
iodide was added to each tube and then the cells were
analyzed by flow cytometry.
Wnt and Notch signaling in MSCs-HSCs co-cultures by
western blot
P- and C-MSCs were irradiated and cell lysates were
prepared after 96 h of irradiation in RIPA buffer. For
expanded cells, CD34+ cells were sorted after expansion
and the cell lysate was prepared in RIPA buffer. A total
of 30 μg of protein was loaded on 10 % SDS-PAGE. Pro-
tein samples were then transferred to a PVDF mem-
brane and overnight blocking with 5 % BSA in TBST
was carried out. For detection, the panel of antibodies
listed below (Cell Signaling Technology) was used. For
detection, a chemiluminescent based detection kit from
Cell Signaling Technology was used. Densitometric ana-
lysis was performed using Image J software and each
protein was normalized to the respective β-actin levels.
Primary antibodies were: β-catenin (D10AB) XP rabbit
mAB, phospho β-catenin (Ser33/37/Thr41), phospho β-
catenin (Ser552), TCF-1 (C63D9) LEF1 (C12A5), Dll-1,
jagged-1, notch1(D6F11), cleaved notch 1 (NICD V1744)
(D3BB), Bmi-1 and Hes. Secondary antibodies were:
anti-rabbit IgG HRP-linked Ab and anti-Mouse IgG
HRP-linked Ab.
Cytokine array
Cytokines and chemokines present in the CMs were
measured using the human Cytokine Array C5 (AAH-
CYT-5-8) following the manufacturer’s instructions
(Ray Biotech, Norcross GA, USA). Densitometry ana-
lyses were performed using Image J software. All values
were normalized according to the mean intensity of
positive and negative controls. Fold change was calcu-
lated according to the manufacturer’s instructions.
Statistical analysis
The statistical differences between groups were analyzed
by one way repeated measure analysis of variance using
the software SIGMA STAT (Jandel Scientific Corporation,
San Rafael, CA, USA) for all the experiments. The values
were plotted as mean ± standard deviation Probability
values *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001 were consid-
ered statistically significant.
Results
C- and P-MSCs share similar morphology, phenotype and
differentiation potential towards osteoblasts, adipocytes
and chondrocytes
First, we isolated MSCs from cord (C-MSCs) and placenta
(P-MSCs). C- and P-MSCs had similar fibroblastic mor-
phologya (Fig. 1a). C- and P-MSCs showed similar marker
expression of molecules such as CD44, CD73, CD105 and
CD90, and were found to be negative for CD34, CD45,
CD14, CD19, CD11b and HLA-DR which is in accordance
with the International Society for Cellular Therapy criteria
for defining MSCs [16] (Fig. 1b). Furthermore, we evalu-
ated their multi-lineage differentiation potential by indu-
cing them to differentiate into osteoblasts, adipocytes, and
chondrocytes. We found that C- and P-MSCs could be
differentiated into all three lineages (Fig. 1c).
P-MSCs were superior to C-MSCs and closer to BM-MSCs
for the expansion of primitive HSCs
We next compared C-MSCs and P-MSCs for their ability
to support hematopoiesis. Initially we used C-MSCs and
P-MSCs isolated from different donors. As we observed
striking differences in the expansion efficiency of the two
MSCs (data not shown), expansion was attempted using
C- and P-MSCs from paired samples.
Equal numbers of the CD34+cells from a single cord
blood unit were seeded separately on pre-established
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Fig. 1 (See legend on next page.)
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irradiated C- and P-MSCs obtained from the same donor
and were cultured for ten days. CD 34+ cells expanded on
P-MSCs (P-MSCs:CD34+ co-cultures) displayed a signifi-
cant (two-fold) increase in total nucleated cell (TNC)
yield, a 2.5-fold increase in immature hematopoietic pro-
genitors (CD34+CD38−) and a higher proportion of the
most primitive CD133+ cells compared to those expanded
with C-MSCs (C-MSCs:CD34+ co-cultures) (Fig. 2a).
Figure 2b upper panel is a dot plot representation which
shows an increase in the CD34+CD38− cells (39.5 %) in
the P-MSCs:CD34+ co-cultures while C-MSCs:CD34+ co-
cultures harbored committed cells CD34+CD38+ (34.9 %).
The histogram of CD133 expression on CD45+CD34+
cells from a representative sample is shown in Fig. 2b
(lower panel).
To further validate our observation we compared the
hematopoietic supportive function of C-MSCs and P-
MSCs with that of the gold standard, i.e., BM-MSCs.
BM-MSCs were thus used as a positive control. BM-
MSCs used in these experiments were first characterized
morphologically, phenotypically, and by studying their
differentiation ability towards three lineages, i.e., osteo,
adipo, and chondro. They were found to satisfy the cri-
teria laid down by ISCT to be identified as MSCs (see
Additional file 1: Figure S1a and b). When the three
types of MSCs were compared for their ability to expand
UCB HSCs, it was observed that P-MSCs though not su-
perior to BM-MSCs, were closer to them. On the con-
trary, C-MSCs were found to be the least efficient in
expanding UCB HSCs. This was evident from higher ex-
pansion of the CD34+ CD38− sub-population and the
most primitive CD133+ fraction (see Additional file 1:
Figure S1c), as well as from their higher clonogenicity
(see Additional file 1: Figure S1d) when the CD34+ cells
were expanded on BM-MSCs and P-MSCs as compared
to C-MSCs.
P-MSCs expanded HSCs without hindering their quiescence
state
Since P-MSCs had resulted in the massive expansion of
HSCs, we next checked if the expansion was caused at the
expense of exhausting the stem cell pool. A significantly
higher percentage of CD34+ cells were in the G0/G1 phase
in P-MSCs:CD34+ co-cultures as compared to the C-
MSCs set (Fig. 2c). The left panel of Fig. 2c shows a repre-
sentative FACS profile of PI based cell cycle wherein an
increase in the cycling HSCs (as represented by the S/
G2M phase of the cell cycle) is seen in C-MSCs:CD34+
co-cultures. Figure 2d depicts a representative FACS
profile of Hoechst and PyroninY based resolution of the
G0/G1 phase of the cell cycle, where P-MSCs:CD34+ co-
cultures showed that 37 % of the CD34+ cells were in the
G0 phase as opposed to 17 % in C-MSCs:CD34+ co-
cultures. This observation clearly indicates that P-MSCs
supported proliferation of CD34+ cells without comprom-
ising its quiescence state.
CD34+ cells expanded with P-MSCs exhibited augmented
in vitro functional attributes
Owing to the fact that C- and P-MSCs co-cultures pre-
sented differences in the phenotype of the expanded
population, we next determined their functionality. P-
MSCs:CD34+ co-cultures showed greater clonogenicity
as evaluated by CFU assay and manifested significantly
higher BFU-E (four-fold), CFU-GEMM (1.6-fold), CFU-
MK (1.5-fold), and total CFU (1.5-fold) as compared to
C-MSCs:CD34+ co-cultures (Fig. 3a).
We further analyzed the self-renewal capacity of
expanded cells by the LTC-IC assay. Both co-cultures
revealed the formation of differential colonies in the
LTC-IC assay. However, P-MSCs:CD34+ co-cultures
harbored significantly higher total LTC-IC units as
compared to C-MSCs:CD34+ co-cultures (Fig. 3b).
Trans-well migration assay is an in vitro method to en-
sure chemotaxis of expanded cells towards SDF-1α which
is an important step for their successful lodgment in the
BM. Cells expanded on P-MSCs showed a significantly
higher number of migratory cells than cells expanded
on C-MSCs (Fig. 3c). Upon analysis of the migrated
fraction it was observed that the migrated fraction of P-
MSCs:CD34+ co-cultures had approximately two-fold
more primitive CD34+CD38−cells than cells co-cultured
with C-MSCs (Fig. 3d). This augmented chemotactic re-
sponse was attributed to the significantly higher percent-
age of CD34+CXCR-4+ population in the P-MSCs:CD34+
co-cultures than in the C-MSCs:CD34+ co-cultures
(Fig. 3e). A representative FACS profile is shown as an
inset in Fig. 3e.
After transplantation, HSCs establish themselves in
the microenvironment via adhesive interactions with
cellular and ECM components. We next checked their
ability to adhere to fibronectin in vitro. Cells expanded
(See figure on previous page.)
Fig. 1 C- and P-MSCs displayed similar morphology and immuno-phenotype. a Fibroblastic morphology exhibited by C- and P-MSCs as seen
under phase contrast microscope (10X). b Histogram profile of representative samples of C- and P-MSCs exhibiting expression of markers such as
CD44, CD90, CD73, and CD105. No expression was found for CD45, CD34, CD14, CD19, CD11b, and HLA-DR. c Upper panel represents osteogenic
differentiation of MSCs by staining with alizarin red S. Middle panel is for adipogenic differentiation confirmed after lipid droplets stained by oil
red o. Chondrogenic differentiation of C- and P-MSCs confirmed with Alcian blue stain. C-MSCs cord-derived mesenchymal stem cells, P-MSCs
placenta-derived mesenchymal stem cells
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on P-MSCs exhibited significantly superior adhesion to
fibronectin as evident from the higher number of crystal
violet stained cells seen attached to fibronectin (Fig. 3f
inset), as compared to the cells expanded on C-MSCs.
The attachment was also quantified by lysing the cells
and measuring the absorbance at 550 nm (Fig. 3f ).
Co-culturing of CD34+ cells with P-MSCs exhibited
enhanced SCID repopulation ability
Primary engraftment
Expanded cells (106) were infused into sub-lethally irra-
diated NOD/SCID mice and four weeks after infusion
short term engraftment in the BM was assessed by
probing human CD45 cells against the host murine
CD45 background. An irradiated mouse infused with
PBS was used as a negative control. Cells expanded on
P-MSCs showed significantly higher chimerism in the
BM and spleen of NOD/SCID mice than those ex-
panded on C-MSCs (Fig. 4a and b). Representative
FACS dot plots, revealing a higher percentage of
HuCD45+ cells in the BM of NOD/SCID mice infused
with cells expanded on P-MSCs, are shown in Fig. 4c.
The multi-lineage engraftment was confirmed by exam-
ining the donor-derived CD34 population, myeloid cells
(CD33), and lymphoid cells (CD3, CD19, and CD56) in
the BM of recipient mice. No predisposition for any
specific lineage was observed (Fig. 4d). Further donor-
derived committed progenitors were evaluated by an in
vitro colony formation assay on MBM using human
specific growth factors. A significantly higher CFU content
was found in the BM of mice that received cells from P-
MSCs:CD34+ co-cultures after four weeks (Fig. 4e).
To ensure the long term engraftment potential, the
presence of human CD 45+ cells was also evaluated in the
MBM after 12 weeks. Approximately three- and 1.5-fold
higher chimerism was detected in BM and spleen, respect-
ively, with the cells from P-MSCs:CD34+ co-cultures than
with the cells from C-MSCs:CD34+ co-cultures (Fig. 4f
and g). A FACS profile depicting the same is shown in
Fig. 4h. It should be noted that the percentage of huCD45
increased in the MBM after 12 weeks owing to the in vivo
proliferation of the infused cells. The engrafted cells were
able to undergo multi-lineage differentiation as shown in
Additional file 2: Figure S2a. Significantly higher human
CFC content was obtained with P-MSCs:CD34+ co-
cultures as quantified and depicted in Additional file 2:
Figure S2b.
Secondary transplantation
A serial transplantation assay was carried out to ensure
the in vivo self-renewal of co-cultured HSCs. For that, BM
cells from the primary recipient were harvested 12 weeks
post transplantation and 105 sort-purified huCD45 were
re-infused into sub-lethally irradiated secondary recipient
NOD/SCID mice. Four weeks post transplantation, cells
from the P-MSCs:CD34+ co-cultures gave rise to 2.5-fold
and two-fold higher chimerism in BM and spleen, respect-
ively, than with C-MSCs as feeders (Fig. 4i and j). A
representative FACS profile is depicted in Fig. 4k. The
engrafted cells retained their multi-lineage differenti-
ation potential as depicted in Additional file 2: Figure
S2c which was further confirmed by quantitating hu-
man derived CFC in MBM by the CFU assay, as shown
in Additional file 2: Figure S2d.
P-MSCs supported survival of CD34+ cells via up-regulation
of anti-apoptotic BCl-2 protein
We next determined if the above observed improvement
was due to a difference in the survival of the cells
expanded with the two feeders. A significant reduction
was observed in the apoptosis in the P-MSCs:CD34+ co-
cultures as opposed to that with C-MSCs:CD34+ co-
cultures. A significantly higher percentage of annexinV−PI
−cells (viable cells) were observed in the total (1.2-fold)
and CD34+ (1.5-fold) compartment in the P-MSCs:CD34+
co-cultures than in the C-MSCs:CD34+c o-cultures
(Fig. 5a). Figure 5b depicts the FACS profile of a repre-
sentative sample.
In order to study the mechanism behind this differen-
tial survival, the expression of BCl-2 and Bax was eval-
uated. It was found that P-MSCs had significantly up-
regulated BCl-2 expression in the primitive (CD34+CD38
−) (57.34 ± 3.45 %) and progenitor (CD34+CD38+) (~95 %)
populations, while relatively low expression was observed
in the totally differentiated cells (CD34−CD38+) (52.32 ±
4.23 %). In sharp contrast, C-MSCs showed the highest
expression of BCl-2 in totally differentiated cells (≥95 %)
(See figure on previous page.)
Fig. 2 P-MSCs supported robust expansion of CD34+ cells without deterring their quiescence state. a Co-culturing of CD34+ cells with P-MSCs
harbored a significantly higher TNC yield, CD34+CD38− and CD133+ cells than C-MSCs as feeders. b Upper panel- A representative FACS dot plot
showing higher CD34+CD38− cells with P-MSCs as feeders. Lower panel- A representative FACS histogram depicting total CD34+CD133+ cells in
the co-culture C- and P MSCs as feeders. c Cell cycle analysis demonstrated an increase of CD34+ cells at G0/G1 phase with P-MSCs as feeders
and higher numbers of cycling CD34+ cells in cultures comprised of C-MSCs as feeders. d FACS dot plot profile of Hoechst and PyroninY based
cell cycle analysis showing P-MSCs as feeders had a higher percentage of CD34+ cells in G0 (quiescence) stage in the co-cultures with P-MSCs
than C-MSCs. Data are represented as mean ± standard deviation from three independent sets of experiments. *p ≤ 0.05, **p ≤ 0.01, and
***p ≤ 0.001 P-MSCs placenta-derived mesenchymal stem cells, C-MSCs cord-derived mesenchymal stem cells, FACS fluorescence-activated cell sorting
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and much lower expression in the primitive (17.98 ±
3.76 %) and progenitors (79.12 ± 1.45 %) populations.
Conversely, P-MSCs:CD34+co-cultures demonstrated sig-
nificantly lower levels(≤60 %) of Bax protein in the primi-
tive population (5.25 ± 1.25 %), progenitors (41.06 ±
3.69 %), and totally differentiated cells (59.76 ± 5.45 %),
while the Bax expression was higher in the primitive
population (38.54 ± 5.85 %), progenitors(94.23 ± 2.15 %),
and totally differentiated cells (90.56 ± 2.55 %) with C-
MSCs as feeders (Fig. 5c). It should be noted that the
percentage of Bax+CD34+CD38− was negligible in the cells
expanded on P-MSCs.
We have earlier reported that the addition of anti-
apoptotic agents resulted in increased expansion efficiency
of suspension cultures of UCB CD34+ cells [17]. Since
higher levels of apoptosis were detected in the C-
MSCs:CD34+ co-cultures, we checked if this system could
be made equivalent to the P-MSCs co-cultures by the
addition of anti-apoptotic molecules. Addition of the pan-
caspase inhibitor zVADfmk (500nM) and the calpain-1
inhibitor zLLYfmk (15 μM) significantly increased the
yield of TNC (see Additional file 3: Figure S3a) and primi-
tive cells (see Additional file 3: Figure S3b) compared to
those without inhibitors. Also, an improvement was seen
in the functionality of the cells expanded with inhibitors
as assessed by the CFU assay (see Additional file 3: Figure
S3c), in vitro migration towards SDF1α (see Additional file
3: Figure S3d) and in vitro adhesion to fibronectin (see
Additional file 3: Figure S3e).
Physical interaction between P-MSCs and CD34+ cells is
indispensable for the beneficial effect of P-MSCs
Next we checked if the modulatory effect of P-MSCs
was contact or cytokines dependent. A significant re-
duction (≥50 %) was observed in the TNC yield (see
Additional file 4: Figure S4a), the total CD34+ content,
and primitive content (see Additional file 4: Figure S4b)
in non-contact cultures as compared to contact cul-
tures of P-MSCs with CD34+ cells. However, non-
contact co-cultures of C-MSCs showed a marginal re-
duction in cell yield (see Additional file 3: Figure S3a).
The viability of the cells in the non-contact cultures of
P-MSCs was greatly compromised, as evident from a
significant reduction in the percentage of total live
(48.62 %) as well as CD34+ cells (38.67 %) (see Additional
file 4: Figure S4c). On the contrary, no change in the via-
bility of non-contact C-MSCs culture was observed (data
not shown). Thus, physical contact with the P-MSCs is a
key for the maintenance of HSCs.
To identify the molecular basis of these interactions, we
carried out a series of blocking experiments. Out of the
myriad of interacting molecules, we chose to focus on
integrin (α4β1/VCAM-1 and α5β1/fibronectin) and SDF-
1α/CXCR-4 since they are involved in providing survival
signals to HSCs in the niche. Blocking of VLA-4(α4β1),
VLA-5(α5β1), and CXCR-4 on CD34+ cells was done
singly or in combination with the blocking antibodies.
The unblocked/blocked cells were then co-cultured with
respective stroma for 96 hrs and the proliferation was
assessed by MTT. Individual blocking of the integrins had
minimal effect on the survival of CD34+ cells in the co-
cultures with C-MSCs and P-MSCs (see Additional file
4: Figure S4d,e). Blocking with individual or combina-
tions of antibodies had no effect on the proliferation
(see Additional file 4: Figure S4d), clonogenic ability
(see Additional file 4: Figure S4f ) and survival (see
Additional file 4: Figure S4h) of the cells expanded on
C-MSCs. In P-MSCs:CD34+ co-cultures, however, all
the above parameters were compromised, particularly
upon blocking integrins in combination with CXCR-4 (see
Additional file 4: Figure S4e, g.i).
The results clearly indicate that P-MSCs exert their ef-
fect partly via integrin and SDF-1α mediated axis.
Enhanced expansion on P-MSCs can be attributed to the
functional differences between the two feeders
With P- and C-MSCs having exhibited differences in the
hematopoiesis supportive function, we further investi-
gated the indigenous differences between these two stro-
mal populations. P-MSCs showed a significantly higher
rate of proliferation than C-MSCs (Fig. 6a). P-MSCs
retained significantly higher clonogenecity even at low cell
count (103) cells as compared to C-MSCs (Fig. 6b and
inset). C- and P-MSCs could be differentiated into
osteoblasts, adipocytes, and chondrocytes. However, quali-
tatively and quantitatively P-MSCs displayed greater
(See figure on previous page.)
Fig. 3 CD34+ cells expanded on P-MSCs have augmented in vitro functionality of the expanded cells. a P-MSCs:CD34+ co-cultures displayed
higher blast-forming unit erythroid (BFU-E), granulocyte–monocyte (GM), granulocyte-erythroid-monocyte megakaryocyte (GEMM), and
megakaryocytes (MK) colonies when compared with C-MSCs as feeders. b P-MSCs as feeders maintained significantly higher LTC-IC units than
C-MSCs. c Trans well migration assay displayed significantly augmented migration of the expanded cells towards SDF-1α in the P-MSCs set as
compared to the C-MSCs set. d Migrated fraction from the co-culture with P-MSCs revealed significantly higher numbers of primitive CD34
+CD38−cells. e Superior migratory response might be attributed to the higher percentage of CD34+CXCR-4+ cells in co-cultures with P-MSCs
as feeders. f Quantitation of the attachment to the fibronectin was carried out after lysing the adhered cells and measuring color intensity at
570 nm. The inset shows sort-purified CD34+ expanded on P-MSCs adhered to fibronectin in higher numbers. Data are represented as mean ±
standard deviation from three independent sets of experiments. *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001. P-MSCs placenta-derived mesenchymal
stem cells, C-MSCs cord-derived mesenchymal stem cells, LTC-IC long term culture initiating cell
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osteogenic potential as compared to C-MSCs (Fig. 6c left
panel). To corroborate these findings, we further checked
the levels of RUNX-2 in P-MSCs and C-MSCs. It was
found that the expression of RUNX-2 was three-fold
higher in P-MSCs (Fig. 6d).
Some of the attributes of P-MSCs, such as predispos-
ition to the osteoblastic lineage and higher RUNX-2 ex-
pression, were found to be similar to MSCs found in the
endosteum, where hypoxia leads to the stabilization of
HIF-1α which is a key regulator of hematopoiesis.
Therefore, we checked if there was any difference in
HIF-1α level in both MSC populations. P-MSCs showed
significantly higher normoxic stabilization of HIF-1α
than C-MSCs. Fig. 6e shows the confocal images of the
nuclear stabilization of HIF-1α in C- and P-MSCs under
normoxic conditions. No difference was observed for
hypoxic stabilization of HIF-1α in C and P-MSCs (data
not shown).
The balance between differentiation and maintenance
of the stem cells is regulated by complex molecular
mechanisms involving soluble factors and cell-cell inter-
actions. Therefore, we compared the secretory profile of
C-MSCs and P-MSCs using a semi-quantitative cytokine
array (Fig. 6g). The majority of the cytokines secreted by
C-MSCs were of a pro-inflammatory nature with a more
than two-fold up-regulation of IL-1α, IL-1β, MCP-2,
MCP-3, and MIP-3α observed, whereas the quantities of
these cytokines were negligible in the CM of P-MSCs
except for HGF (Fig. 6f and h). The graph represents a
quantitative analysis of two independent paired samples.
P-MSCs displayed higher Wnt activation resulting in
improved Notch signaling in the expanded HSCs
To elucidate the molecular mechanism behind the better
hematopoiesis observed in P-MSCs:CD34+ co-cultures,
we evaluated the levels of the Wnt and Notch signaling
pathways, which are linked to self-renewal and mainten-
ance of HSCs. We observed a 1.5-fold higher expression
of β-catenin, an effector of in irradiated P-MSCs than in
irradiated C-MSCs (Fig. 7a). Further, phosphorylation at
the ser-33/37/Thr41 residue which is linked to degrad-
ation of β -catenin mediated by GSK-3β was found to be
reduced in the P-MSCs. The level of activator phosphoryl-
ation at residue ser-552 by AKT/PKA was also found to
be 1.3-fold higher in P-MSCs. A downstream target of the
canonical β–catenin pathway, the levels of TCF were
found to be 1.5-fold higher in P-MSCs stromal cells.
Further, promoters of jagged-1 and δ-like one (dll-1), also
shown to be targets of β-catenin, were found to be up-
regulated in P-MSCs (Fig. 7a). Therefore, we investigated
the corresponding activation of notch signaling in the
HSCs expanded in the co-culture. Figure 7b shows signifi-
cantly higher expression of total Notch 1 and cleaved
Notch 1(NICD form) in the CD34+ cells expanded on P-
MSCs (1.5-fold). The downstream targets of Notch, Bmi-1
and Hes-1 were also found to be up-regulated 2.5-fold
and 1.2-fold, respectively, in the P-MSCs:CD34+ co-
culture (Fig 7c). Collectively, these results indicate that
higher levels of Wnt/β-catenin signals in the P-MSCs re-
sulted in the activation of Notch signaling in the CD34+
cells.
Discussion
Ex vivo expansion of UCB HSCs is attempted to increase
the cell dose for HSCs transplantation in adult patients
[1, 4, 5]. HSCs are either expanded in suspension cul-
tures or in support with the different cell types from the
hematopoietic niche [6, 8–10]. Among the different cell
types used for expansion of HSCs, MSCs have been
found to be the most appropriate feeders [4]. Although
BM remains the chief source of MSCs, obtaining this
source involves an invasive procedure, thus posing a risk
to the donor. The quality of MSCs is also influenced by
the age of donors. On the contrary, the fact that MSCs
from neonatal tissues can be isolated with ease, with no
harm to the donor, and their primitive nature indisput-
ably poses an attractive alternative to BM-MSCs. Thus,
perinatal tissues may be ideal sources for cell therapy
(See figure on previous page.)
Fig. 4 P-MSCS imparts significantly higher SCID repopulating ability on expanded CD34+ cells than C-MSCs. a,b At four weeks post transplantation
(short term engraftment) the bone marrow(a) and spleen(b) of the mice receiving cells expanded on P-MSCs showed a significantly higher percentage
of human CD45+ cells. Each dot in the graph represents an individual animal. c Representative FACS dot plots showing a higher percentage of human
CD45+ cells in the BM of NOD/SCID mice infused with cells expanded on P-MSCs on the background of murine CD45+ cells. d Donor derived7 multi-
lineage engraftment was seen in the BM of NOD/SCID mice for P- and C-MSCs expanded sets as determined by CD34 (stem cells), CD33 (myeloid
cells), CD56(NK cells), CD19 (B cells), and CD3 (T cells). e Donor-derived committed progenitors were higher in the BM of mice receiving cells expanded
on P-MSCs than on C-MSCs as evaluated by performing an in vitro colony formation assay on MBM using human specific growth factors. f, g Long
term engraftment (12 weeks) indicated significantly higher chimerism (% human CD45) was detected in the BM (f) and spleen (g) of NOD/SCID
mice receiving cells from P-MSCs co-cultures. h Representative FACS dot plots showing higher percentage of human CD45+ cells in BM of
NOD/SCID mice infused with cells expanded on P-MSCs in the murine CD45+ background after 12 weeks. i, j Serial transplantation assay
showed a significantly higher percentage of human CD45+ in BM (i) and spleen (j), the secondary recipient receiving cells from mice infused
with cells expanded on P-MSCs. k Representative FACS dot plots showing a higher percentage of human CD45+ cells in the BM of NOD/SCID
mice infused with cells from primary recipient. Data are represented as mean ± standard deviation from ten different mice. (n = 10) *p ≤ 0.05,
**p ≤ 0.01, and ***p ≤ 0.001. P-MSCs placenta-derived mesenchymal stem cells, C-MSCs cord-derived mesenchymal stem cells, FACS
fluorescence-activated cell sorting, BM bone marrow
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[13]. C- and P-MSCs are being extensively studied with
reference to their immune modulatory functions and
trans-differentiation potential and have proven to be bet-
ter than BM-MSCs [14]. C-MSCs are further seen as a
promising alternative to BM-MSCs as feeders for
expanding HSCs [18, 19]. However, the potential of P-
MSCs as feeders for HSCs expansion is probably under-
estimated while it is being explored as a valuable source
for cell replacement therapies. Despite extensive com-
parison of MSCs derived from these tissues with the
BM-MSCs, to date none of these studies have directly
compared the hematopoietic supportive function of C-
MSCs with that of P-MSCs. We found striking differences
in their ability to serve as feeders, in that P-MSCs were
found to be better feeders than C-MSCs for the support of
ex vivo hematopoiesis. Furthermore, our observation with
Fig. 5 Co-culturing of CD34+ cells with P-MSCs reduced the level of apoptosis and expansion of the primitive HSCs by preventing apoptosis via
up regulation of BCL-2. a Higher percentage of live TNC as well as gated CD34+ cells were detected in P-MSCs:CD34+ co-cultures. Inset depicts
representative FACS profile depicting the same P-MSCs:CD34+ co-cultures (Lower panel), C-MSCs:CD34+ co-cultures (Upper panel). b Significantly
higher levels of Bcl-2 were detected in CD34+CD38− cells from the P-MSCs:CD34+ co-cultures. Co-cultures of C-MSCs displayed higher Bcl-2 levels
in CD34+CD38+ and CD34−CD38+ cells. Bax expression was significantly higher in all the subsets from C-MSCs: CD34+ co-cultures. Data are represented
as mean ± standard deviation from three different independent experimental sets. *p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001. P-MSCs placenta-derived
mesenchymal stem cells, TNC total nucleated cells, FACS fluorescence-activated cell sorting, C-MSCs cord-derived mesenchymal stem cells
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the BM-MSCs as positive control additionally strengthens
the inference that P-MSCs are equally as competent as
BM-MSCs for supporting HSC expansion as opposed to
C-MSCs. However, since our primary aim here was to
compare C- and P-MSCs, the detailed mechanism under-
lying the difference in the ability to support hematopoiesis
was studied with respect to C- and P-MSCs only and not
with BM-MSCs.
C-MSCs and P-MSCs were found to be morphologic-
ally and phenotypically similar but it was observed that
P-MSCs could be cultured over 11–15 passages, as op-
posed to C-MSCs that could be maintained for only
seven to eight passages (data not shown). P-MSCs were
found to be sturdier as they sustained the transition
from FBS-containing medium to the xenofree medium
consisting of cord blood derived plasma better than C-
MSCs [15]. These advantages make P-MSCs undoubt-
edly better and more convenient to maintain in cultures
than C-MSCs. The superiority of P-MSCs for supporting
the expansion of functionally superior and transplantable
HSCs was established from the results of an array of in
vitro and in vivo assays. P-MSCs promoted better expan-
sion in terms of primitive progenitor content, CFU and
LTC assays with improved adhesive and migratory proper-
ties. The results of in vivo assays, such as short/long term
and secondary engraftment in the NOD/SCID mouse
model, left little doubt that P-MSCs as feeders are more
efficient at expansion of UCB HSCs than C-MSCs.
While optimizing the co-culture system, we opted to
select irradiated MSCs as feeders for expansion of
HSCs. In a clinical scenario, prior to HSC transplant-
ation, patients usually undergo myeloablation in the
form of radiation therapy. The transplanted HSCs then
lodge on the irradiated stroma, proliferate, and estab-
lish hematopoiesis. Thus, irradiated stroma probably
stimulates the HSCs. Taking this fact into consider-
ation, along similar lines, we also compared the effect
of unirradiated and irradiated MSCs on their capacity
to support hematopoiesis and found that indeed irradi-
ated MSCs had substantially increased efficiency to ex-
pand HSCs (data not shown). Available literature also
supported our observation. Celebi et al. [20] have re-
ported that irradiated MSCs partly mimic the endosteal
niche thereby supporting better expansion of HSCs ex
vivo. Furthermore, Walenda et al. [21] highlights the
maintenance of primitive CD34+CD38− cells after cul-
turing on irradiated bone marrow MSCs.
Next, in an attempt to seek the differences in the charac-
teristics of the two feeders that regulate the hematopoietic
supporting ability, it was found that P-MSCs robustly sup-
ported the expansion of primitive HSCs, as opposed to C-
MSCs, that supported the expansion of cells dominant in
CD34+CD38+ and CD34−CD38+ progenitor cells. The ob-
served expansion of different subsets in the two co-culture
systems could be attributed to the differences in cytokines
secreted by C- and P-MSCs. C-MSCs secrete a variety of
the pro-inflammatory cytokines, such as IL-1α, β, GM-CSF
and MCP-2, 3, driving differentiation of HSCs [22], thus
validating the observed expansion of the progenitor popu-
lation and decline in the primitive HSCs content in co-
cultures of C-MSCs. In sharp contrast, the P-MSCs
secreted negligible levels of the above cytokines. Cytokines
secreted by both the MSCs were similar to those reported
in the literature for other MSCs, such as BM-MSCs, adi-
pose MSCs, etc. [23, 24]. Still, we find striking differences
in the levels of their secretion when we compared C- and
P-MSCs. Further, Fong et al. [25] have reported better ex-
pansion of UCB CD34+ cells with the conditioned medium
obtained from Wharton’s jelly-derived MSCs (WJ-MSCs)
than when co-cultured with MSCs. This clearly suggests
that CM of WJ-MSCs plays a role in the expansion of
HSCs even in the absence of the feeder cells themselves,
which supports our observation about the cytokines
secreted by C-MSCs and its effect on the expansion of
committed progenitors.
The improved expansion in co-cultures of P-MSCs,
however, cannot solely be attributed to the presence of
HGF, whose levels were merely two-fold higher in P-
MSCs, as against the levels of C-MSCs cytokines. Our
data on contact and non-contact cultures of P-MSCs
convincingly demonstrate that P-MSCs exert a beneficial
effect only upon physical contact with the HSCs. Thus,
(See figure on previous page.)
Fig. 6 C-MSCs and P-MSCs differ in the functional attributes relevant to expansion of HSCs. a P-MSCs had higher rate of proliferation than C-MSCs as
determined by MTT assay. b P-MSCs exhibited higher clonogenecity than C-MSCs even at lowest cell concentration. Inset depicts the representative
CFU-F colonies stained with crystal violet. c P-MSCs exhibits superior differentiation to osteoblasts depicted by the calcium deposits stained with
alizarin red S (Left panel). Right panel shows quantitative analysis after extraction of the dye and its quantitation at 405 nm. d Superior osteoblastic
differentiation may be due to the pre-osteoblastic nature of P-MSCs by virtue of higher RUNX-2 expression. e Higher normoxic stabilization of HIF-1α
in the nucleus of the P-MSCs than C-MSCs. Left panel shows 3D representations of expression of the HIF-1α as 3-D histograms. Percentage of the
positive nuclei from ten random fields/slide of three independent experiments is represented in the graph. f Fold change in the cytokines expression
by C-MSCs and P-MSC, respectively. Data represented as mean value of two independent paired samples. g C-MSCs had a distinctive secretion profile
mainly of pro-inflammatory cytokines as checked by membrane-based cytokine array. h Represents the hybridization results for a representative
sample. Data are represented as mean ± standard deviation from three different independent experimental sets. *p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001.
P-MSCs placenta-derived mesenchymal stem cells, C-MSCs cord-derived mesenchymal stem cells, HSCs hematopoietic stem cells, CFU-F colony
forming unit-fibroblasts
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we investigated the contribution of other cellular factors
that might be responsible for the expansion of primitive
HSCs. One such crucial factor in deciding the HSC fate is
cell-cell contact, as explained by Da Silva et al. [26]. At
endosteum, HSCs interact with MSCs/osteoblast predom-
inantly via (SDF-1/CXCR-4) or integrin mediated interac-
tions [26, 27]. Likewise, Fonseca et al. [28] reported a
significant increase in the primitive CD34+CD38− cells
which were in close association with MSCs. They further
demonstrated that the basis of physical contact between
HSCs and MSCs was dominated by the SDF-1/CXCR-4
and integrin axis. We also report the dominance of the
SDF-1α and integrin axis in our co-culture comprising P-
MSCs by a series of blocking experiments further under-
scoring the supremacy and specificity of such interactions.
Thus, we believe that P-MSCs utilize similar cellular inter-
actions as BM-MSCs for maintenance of primitive HSCs.
The observed differences in the expanded cells could also
be due to the differential survival of these subsets as
MSC-HSCs co-cultures exhibited reduction in apoptosis
of HSCs [29]. We observed striking differences in the sur-
vival of cells expanded on C-MSCs and on P-MSCs due to
contrasting levels of Bcl-2 and Bax in the different subsets.
Higher Bcl-2 levels were found in the primitive subset
leading to the persistence of this population in P-MSCs
co-cultures. Higher Bcl-2 levels are not only responsible
for the survival of HSCs but several investigators have
established its link with in vivo functionality of HSCs [30,
31]. We indeed found higher primary and secondary en-
graftment of HSCs expanded on P-MSCs than on C-
MSCs. The superior SRC potential of cells expanded on
P-MSCs could be due to the higher migration towards
SDF-1α observed with these cells in vitro which might
have resulted in better migration to BM in irradiated
NOD/SCID mice. Second, being physically attached to the
HSCs the P-MSCs infused along with the graft might be
responsible for better engraftment. This observation is
supported by findings of Hiwase et al. [32] who reported
better engraftment in mice when transplanted with P-
MSCs along with HSCs. Probably the HSCs that are phys-
ically attached to P-MSCs are successfully delivered to the
BM niche. Our observations between contact and non-
contact cultures further strengthen this possibility.
Moreover, P-MSCs were found to be more immature
than C-MSCs as indicated by their higher proliferative
potential and clonogenicity. This might be another rea-
son for better engraftment of cells expanded on P-
MSCs as this conjecture is supported by the findings of
Yim et al. [33].
To understand the molecular basis of the above ob-
served differences we considered the stromal cell medi-
ated Wnt/β catenin signaling and its effects on the HSCs.
Activation of Wnt/β-catenin signaling in stromal cells is
shown to promote hematopoiesis by up-regulating the
expression of the notch ligands (jagged-1, Dll-1) on stro-
mal cells [34]. P-MSCs showed higher β-catenin levels
which may have caused the higher expression of jagged −
1 and Dll-1 on their surface resulting in a corresponding
increase in the notch receptors and its responsive genes in
the CD34+ cells expanded on P-MSCs. We further tried to
elevate the level of Wnt signaling in C-MSCs by lithium
chloride treatment which resulted in a moderate improve-
ment in the expansion of HSCs (data not shown). How-
ever, the contribution of the other signaling pathways is
yet to be determined.
As a consequence of higher Wnt activity, MSC differen-
tiation is skewed towards osteoblast over the other line-
ages [35]. Therefore, in an attempt to establish whether
the observed differences in the two feeder cells might
influence differentiation to osteoblasts, we checked the
level of Runx-2 and found significantly higher expression
in the P-MSCs. According to Chitteti et al. [36], primitive
osteoblasts with high Runx-2 expression resulted in better
promotion of HPC proliferation, additionally strengthen-
ing our observation of superior expansion of HSCs with
pre-osteoblastic P-MSCs. Further, Runx-2 expressing pre-
osteoblasts are predominantly found in the endosteum of
the bones which is hypoxic in nature. To further confirm
this, we checked the HIF-1α levels; there was no differ-
ence in the HIF-1a stabilization in the two feeders when
maintained under hypoxic conditions (data not shown).
We indeed found that P-MSCs showed significantly
higher nuclear stabilization of HIF-1α under normoxic
conditions, corroborating the reports by Palomaki et al.
[37, 38]. Collectively, our data strongly suggest that P-
MSCs partly provide conditions resembling the endosteal
niche of the bone marrow. The similarity between the
placenta and bone marrow could be explained by the fact
(See figure on previous page.)
Fig. 7 P-MSCs displayed higher Wnt activity leading to collateral increase into Notch signaling in the expanded CD34+cells. a Higher expression
of native β-catenin. Phosphorylated β-catenin (ser-552) was found in the P-MSCs. Higher expression of phosphorylated β-catenin (ser-33/34Thr41)
in C-MSCs. The expression of downstream targets of Wnt, TCF, LEF-1, jagged-1 and δ-like one (dll-1) was higher in P-MSCs than C-MSCs. The
graph represents the fold change in the expression after normalization to β-actin. b Sort purified CD34+ cells from P-MSCs. Co-cultures showed
significant up regulation of Notch I and intracellular domain of Notch (NICD). The quantitation of the same is represented as a graph. c The CD34
+ cells expanded on the P-MSCs exhibited higher expression of Hes-1 and Bmi-1, downstream target of Notch, quantitatively represented as a
graph. Data are represented as mean ± standard deviation from three different samples. *p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001. P-MSCs placenta-derived
mesenchymal stem cells, C-MSCs cord-derived mesenchymal stem cells
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that the placenta is a reservoir of HSCs during development
[39], while the endosteum remains a reservoir of HSCs
throughout life by maintaining steady state hematopoiesis
establishing a solid link between bone marrow and pla-
centa. However, we have not done direct comparisons of P-
MSCs with BM-MSCs in this respect as this was not the
main objective of this manuscript. Nonetheless, we found
that P-MSCs have a similar capacity to sustain ex vivo
hematopoiesis as that of BM-MSCs. Thus, P-MSCs appear
to be a non-invasive and clinically equivalent substitute for
BM-MSCs to be used as feeders for expansion of HSCs.
Conclusions
In summary we report here that P-MSCs are more suit-
able as feeders than C-MSCs for expansion of UCB-
derived HSCs. Higher activity of Wnt/Notch signaling,
normoxic HIF-1α stabilization, pro-osteoblastic pheno-
type and HGF secretion along with a drastic reduction
in apoptosis cumulatively add to the improved ability of
HSCs expansion of P-MSCs. Current cell therapy proto-
cols utilize C-MSCs as an alternative to BM-MSCs.
However, our findings underscore the use of P-MSCs
over C-MSCs for optimizing current protocols aimed at
expanding HSCs. Further, since our HSC-MSC co-
cultures were grown in serum free conditions, they hold
potential to be directly translated in the clinical settings.
Additional files
Additional file 1: Figure S1. BM-MSCs and P-MSCs had similar potential
for expansion of CD34+ cells. a BM-MSCs have fibroblastic morphology, can
be differentiated into osteoblasts, adipocytes and chondrocytes. b BM-MSCs
were shown to exhibit expression of CD44, CD73, CD105, and CD90 and
found not to express CD34, CD45, CD14, CD19, CD11b, and andHLA-DR. c
BM-MSCs had robust expansion of total nucleated cells, CD34+CD38−, and
CD133+ cells. d CD34+ cells expanded on BM-MSCs had superior clonogenic
ability. Data are represented as mean ± standard deviation from four
different samples. *p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001. (TIFF 5033 kb)
Additional file 2: Figure S2. Cells expanded on P-MSCs gave rise to
persistent engraftment in NOD/SCID mice. a Superior multi-lineage
engraftment as denoted by donor-derived CD34 (stem cells), CD33
(myeloid cells), CD56 (NK cells), CD19 (B-cells), and CD3 (T-cells) after
12 weeks was detected in bone marrow of animals receiving cells from
P-MSCs co-cultures as opposed to C-MSCs co-cultures (n = 10). b Mice
infused with cells expanded on P-MSCs showed significantly higher
numbers of donor-derived progenitors (CFU) after 12 weeks. c Multi-lineage
engraftment in secondary recipient also showed superiority of the cells
expanded on P-MSCs. (n = 9). d Secondary recipient similarly displayed a
significantly higher number of human CFC in the mice receiving cells from
primary recipient infused with cells from P-MSCs:CD34+ co-cultures. (n = 9).
Data are represented as mean ± standard deviation from ten different mice.
*p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001. (TIFF 2354 kb)
Additional file 3: Figure S3. Addition of apoptotic inhibitors in
C-MSCs:CD34+ co-cultures improved expansion of UCB CD34+ cells. a
Addition of pan caspase inhibitor (zVADfmk) and calpain-1 inhibitor
(zLLYfmk) to the C-MSCs:CD34+ co-cultures significantly improved total
nucleated cell yield in comparison to the control co-cultures. b Significant
increase in the numbers of CD34+CD38− and CD133+ cells was detected
in the co-cultures inclusive of zVADfmk and zLLYfmk as opposed to the
ones without them. c,d,e Apoptotic inhibitors improved the in vitro
functionality of the expanded cells as determined by CFU content (c), in
vitro migration (d) and in vitro adhesion to fibronectin (e), respectively.
Data are represented as mean ± standard deviation from three different
independent experimental sets. *p≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001.
(TIFF 2676 kb)
Additional file 4: Figure S4. P-MSCs favors the expansion of CD34+
cells in a contact dependent manner. a Significant reduction in total
nucleated cells (TNC) was observed in non-contact cultures of P-MSCs
while no effect was seen in non-contact cultures of C-MSCs. b Non-
contact cultures of P-MSCs displayed reduction in the percentage of
CD34+ and CD34+CD38− cells as compared to contact cultures. c Reduction
in the yield of TNC and CD34+ cells was due to an increase in the apoptosis
in non-contact cultures as seen by a decrease in the annexinV−PI− cells in
non-contact cultures. d No change in the proliferation of CD34+ cells either
singly blocked with CD49d (VLA-4), CD49e (VLA-5), and CXCR-4 or in com-
bination with CD49d + CD49e and CD49d + CD49e + CXCR-4 was observed
after co-culturing with C-MSCs for 96 hrs as assessed by MTT assay. e Drastic
reduction was seen in the proliferation of CD34+ cells upon blocking with
CD49d + CD49e, CXCR-4, and CD49d + CD49e + CXCR-4 and co-culturing
with P-MSCs. f Clonogenecity of the cells expanded on C-MSCs remained
unaltered even after blocking with anti-bodies. g Significant reduction was
observed in the progenitor content after blocking the CD34+ cells with the
combination of antibodies and co-culture on P-MSCs. h Percentage of live
population remains unchanged in the blocked set as opposed to the
unblocked set in the co-cultures comprised of C-MSCs. i Viability of the
expanded cells blocked with integrins and CXCR-4 reduced significantly in
co-cultures with P-MSCs as feeders. Data are represented as mean ± standard
deviation from three different independent experimental sets. *p≤ 0.05,
**p≤ 0.01, and ***p≤ 0.001. (TIFF 4452 kb)
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